NWBO Northwest Biotherapeutics, Inc.

$0.16

Northwest Biotherapeutics, Inc. (NWBO) is expected to report earnings on November 12, 2026, after the market close.

Northwest Biotherapeutics Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.